The Lupus Foundation of America (LFA) and its funded researchers will unveil the latest advances in patient-centered research at the American College of Rheumatology (ACR) Convergence 2025 meeting in ...

The U.S. Food and Drug Administration (FDA) has approved Gazyva® (obinutuzumab), developed by Genentech, as a treatment for adults with lupus nephritis (LN), also known as lupus-related kidney disease ...

There are multiple chapters near you. Select your preferred chapter.

A new study has found that women with systemic lupus erythematosus who have problems with memory and thinking (mild cognitive impairment, or MCI) exhibit morphological brain changes.

The Lupus Foundation of America is proud to share its 2025 Impact Report, which highlights the progress we’ve made together ...

A new study has found a significant association between Epstein-Barr Virus (EBV), a highly contagious virus primarily spread through saliva, and systemic lupus erythematosus (SLE), highlighting a ...

The following transcript is automatically generated and may contain typos or misspellings. Please listen to the episode for the most accurate language. Host 0:04 Welcome to The Expert Series brought ...

The U.S. Food & Drug Administration (FDA) has granted approval for a new subcutaneous autoinjector formulation of belimumab (Benlysta®) treatment for children ages five years and older with active ...

The Lupus Foundation of America works with medical experts and people with lupus and their care partners to offer clear, easy-to-use educational materials and toolkits to help you navigate every step ...

Cullinan Therapeutics has announced a licensing agreement with Genrix Bio for global rights to velinotamig, a clinical-stage BCMAxCD3 bispecific T cell engager. The agreement allows Cullinan to ...

In a new study, researchers explored experiences, perceptions, and health effects of a newly developed healthy lifestyle intervention for people with systemic lupus erythematosus (SLE). This study ...